New Filings At The EMA
New medicines under evaluation at the European Medicines Agency.
You may also be interested in...
The European Medicines Agency produces a monthly list of the marketing authorizations that are under review at the agency. The latest list contains just two new entries.
Bayer’s “game-changing” histology-independent treatment is to be made available via the Cancer Drugs Fund.
New drugs from Eli Lilly, Pfizer, Janssen, GSK, Arvelle, BioCryst, Diurnal and Myovant are also among the latest products the European Medicines Agency is evaluating for potential pan-EU approval.